Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Enhance MD vs Gala Health

Two GLP-1 desks, one scoreboard. We put Enhance MD and Gala Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 11 · Grade B

Enhance MD

Visit Enhance MD Full brief →
vs
No. 29 · Grade B−

Gala Health

Visit Gala Health Full brief →

The verdict

Enhance MD takes this head-to-head.

Enhance MD scores 85 to 82 on our six-factor Brief Score — A transparent, tiered compounding provider that lays out every price on the ladder up front — semaglutide, tirzepatide, microdose, and a combo line — with NAD+ care sitting alongside.

That doesn't make Gala Health a bad call — it's best for readers ready to commit to a year of compounded tirzepatide up front, who want it available in all 50 states and like knowing a brand-name ozempic route exists if they ever switch — and who value a menopause/hrt program alongside the glp-1. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
86
78
Supply Reliability
84
84
Transparency
88
74
Access Breadth
80
90
Clinical Oversight
87
85
Track Record
82
82
Enhance MDBrief Score 85 · 82Gala Health

Price, coverage & the tracker

Enhance MDGala Health
Brief Score85/100 (B)82/100 (B−)
Semaglutide$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepayCompounded semaglutide is included in the same From $179/mo yearly-subscription plan; brand-name Ozempic from $1,299/mo cash
Tirzepatide$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepayFrom $179/mo only on the yearly subscription; $199/mo on the 3-month plan (all doses included)
CoverageNot publicly listedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableStableprice stable

Enhance MD: The ladder is fully published, but its rungs are prepay blocks: $212 and $280 are the 12-MONTH rates, while month-to-month is $249 and $329 — and every plan bills every 4 weeks, so a "monthly" plan is 13 charges a year. The $112 is $212 less a dated SUMMER50 coupon, not an entry rate.

Gala Health: Headline compounded-tirz rate unchanged this cycle, but it is a yearly-subscription price — the shortest published plan is three months at $199/mo, and no month-to-month rate exists.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.